| Block bio-contamination. Validated production of sterile liquid gas
Linde has designed the VERISEQ® Sterile Liquid Gas system (SLG) for use in pharmaceutical production. The system supplies sterile liquid nitrogen by liquefying sterile-filtered gaseous nitrogen. New production possibilities with cryogenic temperatures now exist where previously there was a potential risk for microbial contamination. The VERISEQ® SLG system is suitable for many applications such as cryogenic grinding and mixing, various cooling applications, as well as cryogenic storage of biological material. When used in combination with Linde’s VERISEQ® liquid nitrogen (LIN), the VERISEQ® SLG system yields sterile, traceable liquid nitrogen also tested to fulfil the monograph requirements in the major pharmacopoeias.
Designed and documented for pharmaceutical producers
Each VERISEQ® SLG unit is, of course, delivered with suitable documentation to meet the regulatory requirements of the pharmaceutical industry.
Specifications for VERISEQ® SLG units are well-known within GMP (Good Manufacturing Practice), e.g. functional and design specifications. To reduce your validation time and costs, all manufactured units are submitted to a thorough Pre-Delivery Inspection (PDI) before being released. Additionally, Factory and Site Acceptance Tests are included — and commissioning and validation services are also available, such as, assistance with IQ and OQ.
Photo: Anders Barkfeldt |
